Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Upadacitinib effectively treats severe alopecia areata and is safe.

The formulated gel is a promising treatment for alopecia areata.

Minoxidil 0.25 mg with spironolactone 25 mg reduces hair loss and improves hair density in women.

Dextroamphetamine may help treat alopecia areata.

Combining sodium valproate with other epilepsy drugs increases ammonia levels and side effects.

MRI can show unusual brain changes in adrenomyeloneuropathy.

A 90-year-old man was diagnosed with heart failure due to wild-type transthyretin cardiac amyloidosis.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Sublingual minoxidil is safe and well-tolerated for hair loss treatment.

Men over 50 may experience hormone decline causing various symptoms, and proper management is crucial.

Oral and topical minoxidil are similarly effective for hair growth, but oral may work better on the top of the head.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

Low-dose oral minoxidil and finasteride effectively improve hair growth in men with androgenetic alopecia.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

Minoxidil-loaded NLC gel shows potential for effective alopecia treatment.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Minoxidil can cause a rare eye condition, but it was successfully treated with oral Eplerenone in one case.

MXD@CP could be a promising new topical treatment for hair loss.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Topical minoxidil may cause cherry hemangiomas in some users.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.